Gastroenterology and Liver

Colorectal Cancer Screening and Prevention

Colorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality worldwide. Screening and prevention are critical in reducing the incidence and improving outcomes for patients. Various screening methods, including colonoscopy, fecal occult blood tests, and flexible sigmoidoscopy, are used to detect CRC at an early stage when treatment is most effective. Guidelines recommend regular screening starting at age 45 or earlier for individuals with a family history or other risk factors.

Prevention strategies for colorectal cancer include lifestyle modifications and chemoprevention. Dietary changes, regular physical activity, and maintaining a healthy weight can significantly reduce the risk of CRC. Additionally, certain medications and supplements, such as aspirin and calcium, have shown potential in lowering CRC risk. For individuals with hereditary conditions like familial adenomatous polyposis or Lynch syndrome, more intensive surveillance and preventive measures may be necessary.

Advances in screening technology and risk assessment tools have improved the ability to detect colorectal cancer early and personalize prevention strategies. Novel biomarkers and genetic tests are being developed to enhance screening accuracy and identify individuals at higher risk. As research continues to evolve, the focus remains on implementing effective screening programs and preventive measures to reduce the burden of colorectal cancer.